Q4 2021 Holdings
Filed 2022-02-11 | 33 holdings | $157.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $118.0M | 7,648,268 | 75.1% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $10.8M | 379,792 | 6.9% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $10.6M | 232,268 | 6.7% |
| Biocryst Pharmaceuticals Inc.(BCRX) | Common | 09058V103 | $9.2M | 661,951 | 5.8% |
| Axsome Therapeutics Inc.(AXSM) | Common | 05464T104 | $3.9M | 103,405 | 2.5% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $2.9M | 125,000 | 1.9% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $1.3M | 239,888 | 0.8% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $85.9K | 1,844,727 | 0.1% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $34.6K | 1,639,849 | 0.0% |
| MEI Pharma, Inc. | Common | 55279B202 | $33.0K | 12,350,971 | 0.0% |
| Merus N.V. | Common | N5749R100 | $29.5K | 927,302 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $28.4K | 2,388,011 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $24.1K | 3,196,707 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $19.0K | 160,527 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $15.7K | 3,370,982 | 0.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $12.9K | 271,350 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $12.5K | 2,377,031 | 0.0% |
| Essa Pharma, Inc.(EPIEUR) | Common | 29668H708 | $9.5K | 668,688 | 0.0% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $8.9K | 287,893 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $8.7K | 856,798 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $8.6K | 3,425,202 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $7.2K | 446,457 | 0.0% |
| Geron Corporation(GERN) | Common | 374163103 | $6.9K | 5,623,889 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $6.8K | 337,396 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $6.7K | 3,271,532 | 0.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $6.1K | 142,437 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $5.9K | 513,333 | 0.0% |
| Neogenomics Inc.(NEO) | Common | 64049M209 | $4.8K | 140,422 | 0.0% |
| Mirum Pharmaceuticals Inc.(MIRM) | Common | 604749101 | $4.8K | 298,852 | 0.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $3.7K | 146,041 | 0.0% |
| Avadel Pharmaceuticals Plc | Common | 05337M104 | $3.0K | 375,326 | 0.0% |
| Avrobio, Inc. | Common | 05455M100 | $2.5K | 647,918 | 0.0% |
| Inozyme Pharma Inc. | Common | 45790W108 | $2.1K | 302,615 | 0.0% |